Search Results

HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence heart care solutions, announced results from three clinical studies supporting the use of advanced coronary computed tomography angiography -based technologies in the assessment of patients with suspected coronary artery disease.

HeartFlow, Inc., the only non-invasive precision coronary care solution to provide both anatomic and physiologic insights, today announced that new data on HeartFlow Plaque Analysis and its RoadMapTM Analysis will be presented at the 2023 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Boston, MA.

HeartFlow, Inc. announced the launch of the RoadMap analysis, a new AI-enabled product that assists CT readers to accurately*, efficiently, and consistently identify stenoses in the coronary arteries.

HeartFlow, Inc. announced the close of a $215 million Series F funding round by its parent company HeartFlow Holding, Inc., led by Bain Capital Life Sciences with participation from new investor Janus Henderson Investors, and existing investors including Baillie Gifford, Capricorn Investment Group, Hayfin Capital Management, HealthCor, Martis Capital, USVP and Wellington Management.

HeartFlow, Inc., the leader in revolutionizing precision heart care, announced that the results of the Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization will be presented as Late Breaking Science at the upcoming annual American Heart Association conference, held November 5-7 virtually and in Chicago, Illinois.

HeartFlow Holding, Inc., the leader in revolutionizing precision heart care, announced the appointment of Timothy Barabe to its Board of Directors.

HeartFlow Holding, Inc. today announced that it and Longview Acquisition Corporation II (NYSE: LGV), a special purpose acquisition company sponsored by affiliates of Glenview Capital Management, LLC, have mutually agreed to terminate their previously announced business combination agreement, effective immediately, as a result of current unfavorable market conditions.

HeartFlow Holding, Inc ., the leader in revolutionizing precision heart care, today announced the company will be participating in two upcoming virtual investor conferences.